Dicerna Pharmaceuticals has named James Weissman as its new chief business officer.
In this role, he will be responsible for corporate development, strategy, and other operational functions, the company said.
Weissman was previously vice president of business development at drug developer MannKind.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
